Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 12 | 2023 | 2980 | 1.140 |
Why?
|
Enhancer Elements, Genetic | 6 | 2021 | 1365 | 0.990 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2024 | 8611 | 0.910 |
Why?
|
Transcription Factors | 8 | 2024 | 12131 | 0.700 |
Why?
|
Gene Expression Profiling | 14 | 2022 | 9525 | 0.630 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 341 | 0.570 |
Why?
|
Epigenesis, Genetic | 10 | 2024 | 3819 | 0.560 |
Why?
|
Paraffin Embedding | 5 | 2020 | 301 | 0.540 |
Why?
|
Tissue Fixation | 4 | 2020 | 244 | 0.520 |
Why?
|
Histone Code | 1 | 2016 | 159 | 0.480 |
Why?
|
Colorectal Neoplasms | 11 | 2021 | 6942 | 0.480 |
Why?
|
Receptors, Androgen | 6 | 2022 | 1088 | 0.470 |
Why?
|
Rectal Neoplasms | 3 | 2012 | 1182 | 0.460 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1352 | 0.410 |
Why?
|
Formaldehyde | 4 | 2023 | 352 | 0.390 |
Why?
|
Histones | 7 | 2022 | 2584 | 0.340 |
Why?
|
Prostatic Neoplasms | 6 | 2022 | 11083 | 0.330 |
Why?
|
Neoplasms | 10 | 2022 | 22340 | 0.330 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2022 | 2176 | 0.310 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2024 | 1140 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2022 | 5337 | 0.270 |
Why?
|
Adenocarcinoma | 6 | 2021 | 6364 | 0.260 |
Why?
|
Proto-Oncogene Proteins | 4 | 2022 | 4520 | 0.250 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 166 | 0.250 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2016 | 857 | 0.240 |
Why?
|
ras Proteins | 1 | 2009 | 1053 | 0.230 |
Why?
|
Histone Demethylases | 2 | 2024 | 328 | 0.230 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 17075 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2844 | 0.230 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2024 | 139 | 0.220 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 451 | 0.220 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2022 | 792 | 0.220 |
Why?
|
RNA, Messenger | 3 | 2016 | 12768 | 0.220 |
Why?
|
Lipid Peroxidation | 1 | 2004 | 275 | 0.220 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 79 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2023 | 4772 | 0.210 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2017 | 187 | 0.200 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 790 | 0.200 |
Why?
|
HMGN1 Protein | 2 | 2020 | 27 | 0.200 |
Why?
|
Fixatives | 2 | 2020 | 90 | 0.200 |
Why?
|
Up-Regulation | 3 | 2024 | 4137 | 0.190 |
Why?
|
Neoplasm Proteins | 2 | 2024 | 3596 | 0.190 |
Why?
|
Colonic Neoplasms | 4 | 2016 | 2531 | 0.190 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5444 | 0.190 |
Why?
|
Lysine | 3 | 2020 | 991 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 4562 | 0.180 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 192 | 0.180 |
Why?
|
SOXC Transcription Factors | 1 | 2020 | 42 | 0.180 |
Why?
|
SOX9 Transcription Factor | 1 | 2021 | 146 | 0.180 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13451 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 7 | 2020 | 6499 | 0.170 |
Why?
|
Peptides | 1 | 2012 | 4331 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2021 | 632 | 0.170 |
Why?
|
Acetylation | 5 | 2020 | 1053 | 0.170 |
Why?
|
Sciatic Neuropathy | 1 | 2000 | 75 | 0.170 |
Why?
|
Disease-Free Survival | 8 | 2016 | 6832 | 0.170 |
Why?
|
Oncogene Proteins | 2 | 2020 | 710 | 0.160 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 282 | 0.160 |
Why?
|
Carcinoma, Lobular | 2 | 2022 | 471 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 722 | 0.160 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 322 | 0.160 |
Why?
|
Adenosine Deaminase | 1 | 2021 | 251 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9373 | 0.160 |
Why?
|
Mice | 20 | 2024 | 81819 | 0.150 |
Why?
|
3' Untranslated Regions | 2 | 2021 | 515 | 0.150 |
Why?
|
Mutation | 7 | 2022 | 30198 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2021 | 536 | 0.150 |
Why?
|
Cell Differentiation | 4 | 2024 | 11641 | 0.150 |
Why?
|
Prognosis | 18 | 2022 | 29922 | 0.150 |
Why?
|
Cell Transplantation | 1 | 2000 | 473 | 0.150 |
Why?
|
Receptors, Erythropoietin | 2 | 2008 | 145 | 0.140 |
Why?
|
Tumor Escape | 1 | 2020 | 371 | 0.140 |
Why?
|
Choline Kinase | 2 | 2007 | 5 | 0.140 |
Why?
|
Trisomy | 1 | 2018 | 259 | 0.140 |
Why?
|
Cell Lineage | 3 | 2024 | 2573 | 0.140 |
Why?
|
Antigens, Neoplasm | 2 | 2020 | 2002 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2021 | 494 | 0.140 |
Why?
|
Humans | 64 | 2024 | 765968 | 0.140 |
Why?
|
Coenzyme A Ligases | 1 | 2016 | 44 | 0.140 |
Why?
|
Animals | 26 | 2024 | 168764 | 0.130 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1801 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2140 | 0.130 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2022 | 1083 | 0.130 |
Why?
|
Mice, Inbred NOD | 2 | 2020 | 1837 | 0.130 |
Why?
|
Genome | 2 | 2022 | 1753 | 0.130 |
Why?
|
Integrins | 1 | 2020 | 840 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 479 | 0.130 |
Why?
|
Pyrimidines | 2 | 2021 | 3047 | 0.130 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2000 | 605 | 0.130 |
Why?
|
Nuclear Proteins | 4 | 2021 | 5783 | 0.130 |
Why?
|
Hyperalgesia | 1 | 2000 | 514 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2020 | 708 | 0.130 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2034 | 0.130 |
Why?
|
Epigenomics | 4 | 2023 | 959 | 0.130 |
Why?
|
Signal Transduction | 9 | 2022 | 23601 | 0.120 |
Why?
|
Prostate | 3 | 2022 | 1755 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1624 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 545 | 0.120 |
Why?
|
Hepatocytes | 1 | 2022 | 1247 | 0.120 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 654 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2023 | 3655 | 0.110 |
Why?
|
Glycosyltransferases | 1 | 2014 | 114 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11022 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.110 |
Why?
|
Binding Sites | 2 | 2019 | 6001 | 0.110 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 168 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2004 | 3141 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2022 | 2867 | 0.100 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.100 |
Why?
|
Protein Binding | 3 | 2021 | 9296 | 0.100 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13648 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 404 | 0.100 |
Why?
|
Breast Neoplasms | 6 | 2022 | 21056 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2020 | 7599 | 0.100 |
Why?
|
Homeodomain Proteins | 2 | 2019 | 2428 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 320 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1874 | 0.100 |
Why?
|
Computational Biology | 2 | 2021 | 3559 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1892 | 0.100 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6069 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2019 | 1957 | 0.100 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2012 | 108 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11868 | 0.090 |
Why?
|
Apoptosis | 4 | 2020 | 9514 | 0.090 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2013 | 332 | 0.090 |
Why?
|
Transfection | 3 | 2012 | 5743 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1661 | 0.090 |
Why?
|
Protein Array Analysis | 1 | 2012 | 399 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 915 | 0.090 |
Why?
|
Stomach Neoplasms | 2 | 2012 | 1471 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4642 | 0.080 |
Why?
|
Cell Proliferation | 6 | 2022 | 10429 | 0.080 |
Why?
|
Trans-Activators | 1 | 2019 | 2850 | 0.080 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2009 | 44 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1241 | 0.080 |
Why?
|
Frozen Sections | 1 | 2010 | 153 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2900 | 0.080 |
Why?
|
Endonucleases | 1 | 2012 | 372 | 0.080 |
Why?
|
DNA | 1 | 2023 | 7202 | 0.080 |
Why?
|
DNA Methylation | 4 | 2022 | 4424 | 0.080 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2008 | 17 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4752 | 0.080 |
Why?
|
Male | 25 | 2022 | 363698 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3608 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3797 | 0.070 |
Why?
|
Stem Cells | 1 | 2021 | 3540 | 0.070 |
Why?
|
Deoxycytidine | 1 | 2012 | 889 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3401 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2021 | 703 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12056 | 0.070 |
Why?
|
Cell Survival | 4 | 2020 | 5747 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2016 | 59489 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2009 | 2878 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1648 | 0.070 |
Why?
|
Nucleosomes | 2 | 2023 | 494 | 0.070 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11206 | 0.070 |
Why?
|
Cisplatin | 2 | 2012 | 1658 | 0.070 |
Why?
|
Clone Cells | 2 | 2020 | 1672 | 0.070 |
Why?
|
Female | 28 | 2024 | 396112 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5772 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1892 | 0.070 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2007 | 246 | 0.070 |
Why?
|
Neoplasm Metastasis | 5 | 2018 | 4893 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 5995 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2014 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15543 | 0.060 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 3430 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2312 | 0.060 |
Why?
|
Organoids | 2 | 2021 | 739 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6220 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1365 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3646 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2021 | 2942 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 16047 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4900 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2021 | 6113 | 0.050 |
Why?
|
RNA Interference | 3 | 2021 | 2832 | 0.050 |
Why?
|
Aged | 15 | 2018 | 171117 | 0.050 |
Why?
|
Neoadjuvant Therapy | 2 | 2012 | 2895 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9071 | 0.050 |
Why?
|
Survival Analysis | 2 | 2016 | 10070 | 0.050 |
Why?
|
Erythropoietin | 1 | 2007 | 716 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2024 | 14448 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 26 | 0.050 |
Why?
|
Middle Aged | 16 | 2018 | 223009 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22332 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1761 | 0.050 |
Why?
|
Adult | 14 | 2022 | 223044 | 0.050 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 308 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 312 | 0.050 |
Why?
|
HT29 Cells | 1 | 2021 | 187 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9601 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2022 | 81514 | 0.050 |
Why?
|
Genes, APC | 1 | 2021 | 144 | 0.050 |
Why?
|
Deoxycytosine Nucleotides | 1 | 2020 | 13 | 0.050 |
Why?
|
Genes, myc | 1 | 2022 | 393 | 0.040 |
Why?
|
RNA | 2 | 2022 | 2717 | 0.040 |
Why?
|
NF-kappa B | 1 | 2009 | 2485 | 0.040 |
Why?
|
Neurons | 1 | 2000 | 9525 | 0.040 |
Why?
|
Genes, cdc | 1 | 2020 | 113 | 0.040 |
Why?
|
Tubulin | 1 | 2004 | 692 | 0.040 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 58 | 0.040 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2020 | 105 | 0.040 |
Why?
|
Metaplasia | 1 | 2021 | 326 | 0.040 |
Why?
|
Mediator Complex | 1 | 2020 | 106 | 0.040 |
Why?
|
Cyclin E | 1 | 2020 | 156 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2021 | 112 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2020 | 89 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2009 | 5389 | 0.040 |
Why?
|
Base Sequence | 2 | 2021 | 12403 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 691 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 399 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 175 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3537 | 0.040 |
Why?
|
Ligation | 1 | 2000 | 444 | 0.040 |
Why?
|
Disease Progression | 4 | 2021 | 13632 | 0.040 |
Why?
|
Nitriles | 2 | 2018 | 982 | 0.040 |
Why?
|
Lymph Nodes | 3 | 2020 | 3454 | 0.040 |
Why?
|
Blotting, Western | 3 | 2013 | 5020 | 0.040 |
Why?
|
Gene Library | 1 | 2021 | 1067 | 0.040 |
Why?
|
Physical Stimulation | 1 | 2000 | 513 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 257 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 596 | 0.040 |
Why?
|
Introns | 1 | 2021 | 966 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 506 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 327 | 0.040 |
Why?
|
Tamoxifen | 1 | 2022 | 963 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 377 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16721 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2015 | 65188 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 852 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1752 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1749 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2000 | 529 | 0.030 |
Why?
|
Interferons | 1 | 2021 | 714 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 956 | 0.030 |
Why?
|
Genetic Testing | 1 | 2010 | 3595 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 561 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2022 | 995 | 0.030 |
Why?
|
Phenylthiohydantoin | 1 | 2018 | 206 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4353 | 0.030 |
Why?
|
Antioxidants | 1 | 2004 | 1670 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1744 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 862 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 852 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 794 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1072 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1216 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 562 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1578 | 0.030 |
Why?
|
1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2015 | 9 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2008 | 1701 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1885 | 0.030 |
Why?
|
Amino Acids | 1 | 2021 | 1709 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2021 | 1107 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 777 | 0.030 |
Why?
|
Regression Analysis | 2 | 2015 | 6322 | 0.030 |
Why?
|
Cell Membrane | 1 | 2004 | 3634 | 0.030 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2015 | 85 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12795 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1438 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 897 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1106 | 0.030 |
Why?
|
DNA Damage | 1 | 2004 | 2457 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4618 | 0.030 |
Why?
|
Mitochondria | 2 | 2005 | 3673 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2242 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2892 | 0.030 |
Why?
|
Hot Temperature | 1 | 2000 | 1433 | 0.030 |
Why?
|
rab3 GTP-Binding Proteins | 1 | 2013 | 28 | 0.030 |
Why?
|
Calcium Channels | 1 | 2017 | 622 | 0.030 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 276 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3807 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 1995 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4108 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1061 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2045 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1377 | 0.020 |
Why?
|
Young Adult | 3 | 2016 | 59889 | 0.020 |
Why?
|
Immunoblotting | 1 | 2015 | 1644 | 0.020 |
Why?
|
Gene Deletion | 1 | 2020 | 2666 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2000 | 1865 | 0.020 |
Why?
|
Recurrence | 2 | 2015 | 8501 | 0.020 |
Why?
|
E-Selectin | 1 | 2014 | 576 | 0.020 |
Why?
|
Apolipoproteins | 1 | 2014 | 327 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2020 | 1608 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2024 | 4392 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2210 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2968 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4260 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2008 | 2887 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 18071 | 0.020 |
Why?
|
Mice, Nude | 2 | 2007 | 3618 | 0.020 |
Why?
|
Etoposide | 1 | 2012 | 636 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2822 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2014 | 682 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18293 | 0.020 |
Why?
|
Pain Measurement | 1 | 2000 | 3561 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3624 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2535 | 0.020 |
Why?
|
Vincristine | 1 | 2012 | 1039 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5501 | 0.020 |
Why?
|
Chromones | 1 | 2009 | 148 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3890 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2013 | 561 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9550 | 0.020 |
Why?
|
Carboplatin | 1 | 2012 | 789 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3449 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2721 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1748 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 370 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12509 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2453 | 0.020 |
Why?
|
Neoplastic Processes | 1 | 2007 | 35 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4448 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7584 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3946 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2020 | 4913 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 440 | 0.020 |
Why?
|
Cadherins | 1 | 2012 | 900 | 0.020 |
Why?
|
Biological Assay | 1 | 2010 | 627 | 0.020 |
Why?
|
beta Catenin | 1 | 2012 | 1043 | 0.020 |
Why?
|
Sulfones | 1 | 2009 | 447 | 0.020 |
Why?
|
Reference Standards | 1 | 2010 | 1013 | 0.020 |
Why?
|
Morpholines | 1 | 2009 | 577 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20124 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2008 | 602 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 79 | 0.020 |
Why?
|
Time Factors | 3 | 2015 | 40065 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4778 | 0.020 |
Why?
|
Chaperonin 60 | 1 | 2005 | 97 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 2005 | 112 | 0.020 |
Why?
|
Doxorubicin | 1 | 2012 | 2230 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 916 | 0.010 |
Why?
|
Colon | 1 | 2013 | 1795 | 0.010 |
Why?
|
Kidney | 1 | 2020 | 7066 | 0.010 |
Why?
|
Cell Movement | 1 | 2017 | 5194 | 0.010 |
Why?
|
DNA Repair | 1 | 2014 | 2048 | 0.010 |
Why?
|
Pain | 1 | 2000 | 5077 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7562 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9443 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2005 | 412 | 0.010 |
Why?
|
Rats | 1 | 2000 | 23707 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4247 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7851 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 2005 | 192 | 0.010 |
Why?
|
Pyrazines | 1 | 2009 | 1204 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 8041 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1751 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10261 | 0.010 |
Why?
|
Drugs, Investigational | 1 | 2004 | 211 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1505 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2006 | 618 | 0.010 |
Why?
|
Glycolysis | 1 | 2005 | 838 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2927 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2006 | 1187 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3602 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 13024 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39193 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8278 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3586 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6493 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5786 | 0.010 |
Why?
|
Forecasting | 1 | 2006 | 2936 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8529 | 0.010 |
Why?
|
Breast | 1 | 2005 | 1946 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12807 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
Proteome | 1 | 2005 | 1899 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 10383 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2423 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10603 | 0.010 |
Why?
|
Child | 1 | 2022 | 80564 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15398 | 0.010 |
Why?
|
Proteomics | 1 | 2006 | 3910 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3965 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14652 | 0.010 |
Why?
|
Risk Factors | 2 | 2010 | 74840 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54802 | 0.010 |
Why?
|
Genomics | 1 | 2006 | 5929 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 24282 | 0.000 |
Why?
|